Ibnsina Pharma (CAI:ISPH) Debt-to-Asset : 0.25 (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Ibnsina Pharma Debt-to-Asset?

Ibnsina Pharma's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was E£4,217 Mil. Ibnsina Pharma's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was E£854 Mil. Ibnsina Pharma's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was E£20,655 Mil. Ibnsina Pharma's debt to asset for the quarter that ended in Mar. 2024 was 0.25.

Ibnsina Pharma Debt-to-Asset Historical Data

The historical data trend for Ibnsina Pharma's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibnsina Pharma Debt-to-Asset Chart

Ibnsina Pharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.13

0.14

0.20

0.31

0.27

Ibnsina Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Asset	Get a 7-Day Free Trial															0.02	0.27	0.26	0.27	0.25

Competitive Comparison of Ibnsina Pharma's Debt-to-Asset

For the Medical Distribution subindustry, Ibnsina Pharma's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ibnsina Pharma's Debt-to-Asset Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Ibnsina Pharma's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Ibnsina Pharma's Debt-to-Asset falls into.

Ibnsina Pharma Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Ibnsina Pharma's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(3759.268	+	1176.434)	/	18549.811
	=	0.27

Ibnsina Pharma's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(4217.229	+	853.797)	/	20655.087
	=	0.25

Ibnsina Pharma (CAI:ISPH) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Ibnsina Pharma Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Ibnsina Pharma's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Ibnsina Pharma (CAI:ISPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ibnsina Pharma (CAI:ISPH) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Industrial zone 1, PO box 91, Obour, EGY

Website

http://www.ibnsina-pharma.com

Ibnsina Pharma is an Egypt based pharmaceutical distribution company. It is engaged in purchasing and selling in wholesale and distribution of pharmaceutical, semi- pharmaceutical and cosmetic products. It distributes a portfolio of pharmaceutical products from local and multinational pharmaceutical companies to retail pharmacies, wholesalers, hospitals, and public health institutions. In addition, the company also offers services including warehousing and logistics, marketing solutions, importation, and packaging, market research, and analysis.

Ibnsina Pharma (CAI:ISPH) Headlines

No Headlines